About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Living Conditions and Breast Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01626950

Living Conditions and Breast Cancer

The main objective of this study is to estimate of the link (odds ratio) between the precariousness defined by the score SPICE (2 groups: precarious and insecure) and stage at diagnosis (2 groups: CAS...

Lead sponsor: Centre Hospitalier Universitaire de Nīmes•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Centre Hospitalier Universitaire de Nīmes

Our secondary objectives include: * To study the link between cancer stage at diagnosis and diverse parameters describing living conditions * To construct a new score for social fragility based on new data collected in this study, and to compare this score with the EPICES score * To study patient quality of life at study baseline

Age

All ages

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Patient has been correctly informed about the study, and agrees to participate
•The patient must be insured or beneficiary of a health insurance plan
•Incident breast cancer cases (diagnosis based on pathology) excluding sarcoma, classifiable as stage III-IV, surgical cases
•Patient has been correctly informed about the study, and agrees to participate
•The patient must be insured or beneficiary of a health insurance plan
•Incident breast cancer cases (diagnosis based on pathology) excluding sarcoma, classifiable as stage I-II, surgical cases

Exclusion Criteria

•The patient is in an exclusion period determined by a previous study
•The patient is under judicial protection, under tutorship or curatorship
•The patient is pregnant, parturient, or breastfeeding
•The patient is opposed to study participation
•Women not able to answer a questionnaire due to language barriers or due to vascular or degenerative cerebral dysfunction
•It is impossible to correctly inform the patient

Related studies

RECRUITINGPhase 1/2

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

NCT06380816 · Advanced Solid Tumours, Squamous Cell Carcinoma of Head and Neck, and more

Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer Surgery

NCT06608446 · Breast Neoplasms

RECRUITINGPhase 1

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04389632 · Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, and more

RECRUITINGPhase 3

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

NCT06966700 · Breast Neoplasms, Triple Negative Breast Neoplasms, and more

RECRUITINGPhase 3

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

NCT07174336 · Breast Neoplasms, Neoplasm Metastasis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 19, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment684

Start dateMay 2012

Last updatedNov 19, 2025

Condition

Breast Neoplasms

Locations shown

IURC - Laboratoire de Biostatistique d'Epidémiologie et de Recherche Clinique

Montpellier

Equipe Démographie Santé

Montpellier

Registre Tumeurs de l'Hérault

Montpellier

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 19, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions